References
- Bhuva M, Ganger D, Jensen D. Spontaneous bacterial peritonitis: an update on evaluation, management and prevention. Am J Med. 1994; 97: 169–175.
- Sawyer MD, Dunn DL. Antimicrobial treatment of intra-abdominal sepsis. Infect Dis Clin NorthAm. 1992; 6: 545–570.
- Mc Clean KL, Sheehan GJ, Harding GKM. Intra-abdominal infection: a review. Clin Infect Dis. 1994; 19: 100–116.
- Gorbach SL. Intra-abdominal infections. Clin Infect Dis. 1993; 17: 961–967.
- Bartlett JG. Intra-abdominal sepsis. Med Clin North Am. 1995; 79: 599–617.
- Montgomery RS, Wilson SE. Intra-abdominal abscesses: image-guided diagnosis and therapy. Clin Infect Dis. 1996; 23: 28–36.
- Foitzik T, Runkel N. Intra-abdominal sepsis. Curr Op Infect Dis. 1996; 9: 353–358.
- Walker AP, Krepel CJ, Gohr CM, Edmiston CE. Microflora of abdominal sepsis by locus of infection. J Clin Microbiol. 1994; 32: 557–558.
- Grant SW, Hopkins J, Wilson SE. Operative site bacteriology as an indicator of prognostic infectious complications in elective colorectal surgery. Am Surg. 1995; 61: 856–861.
- Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol. 1997; 18: 275–291.
- Verbist L, Verhaegen J, Wouters Ch, Vandenhove G and a multicenter study group. Comparative activity of piperacillin/tazobactam against 5625 isolates from hospitalized patients. J Antimicrob Chemother. 1996; 37: 285–293.
- Pierard D, De Meyer A, Rosseel P, et al. In vitro activity of amoxicillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey. Acta Clin Belg. 1996; 51: 70–79.
- Jacobs MR, Spangler SK, Appelbaum PC. Beta-lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents. Eur J Clin Microbiol Infect Dis. 1992; 11: 1081–1093.
- Bohnen JMA, Solomkin JS, Dellinger EP, Bjornson HS, Page CP. Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement. Arch Surg. 1992; 127: 83–89.
- Brismar B, Malmborg AS, Tunevall G, et al. Piperacillin/tazobactam versus imipenem/cilastatin for treatment of intra-abdominal infections. Antimicrob Ag Chemother. 1992; 36: 2766–2773.
- Polk HC, Fink MP, La Verdiere M, et al. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infections. Am Surg. 1993; 59: 598–605.
- Brismar B, Malmborg S, Tunevall G, et al. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections. J Antimicrob Chemother. 1995; 35: 139–148.